Modulation of Vaccine‐Induced Immune Responses to Hepatitis C Virus in Rhesus Macaques by Altering Priming before Adenovirus Boosting
Author(s) -
Christine S. Rollier,
Ernst J. Verschoor,
Gláucia ParanhosBaccalà,
Joost Drexhage,
Babs E. Verstrepen,
JeanLuc Berland,
Nourredine Himoudi,
Christina Barnfield,
Peter Liljeström,
Juan José Lasarte,
Juan Ruiz,
Geneviève Inchauspé,
Jonathan L. Heeney
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/432517
Subject(s) - virology , priming (agriculture) , immunology , semliki forest virus , immune system , biology , dna vaccination , antigen , cd8 , t cell , virus , immunization , biochemistry , botany , rna , germination , gene
Preventive and therapeutic vaccine strategies aimed at controlling hepatitis C virus (HCV) infection should mimic the immune responses observed in patients who control or clear HCV, specifically T helper (Th) type 1 and CD8+ cell responses to multiple antigens, including nonstructural protein (NS) 3. Given the experience with human immunodeficiency virus, the best candidates for this are based on DNA prime, pox, or adenovirus boost regimens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom